Yayıncı "Massachussetts Medical Society" Tıp Fakültesi için listeleme
Toplam kayıt 1, listelenen: 1-1
-
A phase 3 trial of seladelpar in primary biliary cholangitis
(Massachussetts Medical Society, 2024)Effective treatments for patients with primary biliary cholangitis are limited. Seladelpar, a peroxisome proliferator–activated receptor delta agonist, has potential benefits. METHODS In this phase 3, 12-month, double-blind, ...